CA Patent

CA2370245A1 — Enzyme-activated anti-tumor prodrug compounds

Assigned to Boehringer Ingelheim Pharmaceuticals Inc · Expires 2000-11-23 · 25y expired

What this patent protects

Disclosed are enzyme-activated anti-tumor and anti-metastatic prodrug compounds. The specific enzymes are collegenase(IV) and elastase. Also disclosed are methods of making and using such compounds.

USPTO Abstract

Disclosed are enzyme-activated anti-tumor and anti-metastatic prodrug compounds. The specific enzymes are collegenase(IV) and elastase. Also disclosed are methods of making and using such compounds.

Drugs covered by this patent

Patent Metadata

Patent number
CA2370245A1
Jurisdiction
CA
Classification
—
Expires
2000-11-23
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.